Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes

Journal of Clinical Investigation

Volumn 98, Issue 12, 1996, Pages 2720-2728

  Sakamoto, Naoya ^a   Wu, Catherine H ^a   Wu, George Y ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

catalytic RNA; gene therapy; luciferase reporter gene

Indexed keywords

LUCIFERASE; RIBOZYME; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; BINDING AFFINITY; ENZYME BINDING; GENE EXPRESSION REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTRACELLULAR TRANSPORT; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS ENVELOPE; VIRUS INHIBITION;

EID: 0030481468     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119097     Document Type: Article

References (33)

1. Altman, S. 1989. Ribonuclease P: an enzyme with a catalytic RNA subunit. Adv. Enzymol. 62:1-36.
2. Cech, T.R. 1987. The chemistry of self-splicing RNA and RNA enzymes. Science (Wash. DC). 236:1532-1539.
3. Uhlenbeck, O.C. 1987. A small catalytic oligoribonucleotide. Nature (Lond.). 328:596-600.
4. James, W., and A. Shamkhani. 1995. RNA enzymes as tools for gene ablation. Curr. Opin. Biotechol. 6:44-49.
5. Sakamoto, N., C. Sato, H. Haritani, S. Maekawa, M. Kurosaki, N. Enomoto, Y. Hoshino, J. Tazawa, M. Nishimura, and F. Marumo. 1993. Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infection. J. Hepatol. 17:28-33.
6. Choo, Q.L., G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science (Wash. DC). 244:359-362.
7. Esteban, J.I., R. Esteban, L. Viladomiu, J.C. López-Talavera, A. González, J.M. Hernández, M. Roget, V. Vargas, J. Genesca, M. Buti, and J. Guardia. 1989. Hepatitis C virus antibodies among risk groups in Spain. Lancet. ii:294-297.
8. Kato, N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkoshi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA. 87:9524-9528.
9. Choo, Q.L., K.H. Richman, J.H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, R. Medina-Selby, P.J. Barr et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:2451-2455.
10. Okamoto, H., S. Okada, Y. Sugiyama, K. Kurai, H. Iizuka, A. Machida, Y. Miyakawa, and M. Mayumi. 1991. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J. Gen. Virol. 72:2697-2704.
11. Tsukiyama-Kohara, K., N. Iizuka, M. Kohara, and A. Nomoto. 1992. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 66:1476-1483.
12. Wang, C., P. Sarnow, and A. Siddiqui. 1993. Translation ot human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67:3338-3344.
13. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
14. Kashani, S.M., T. Funato, V.A. Florenes, O. Fodstad, and K.J. Scanlon. 1994. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res. 54:900-902.
15. Zhou, C., I.C. Bahner, G.P. Larson, J.A. Zaia, J.J. Rossi, and E.B. Kohn. 1994. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene. 149:33-39.
16. Lieber, A., and M. Strauss. 1995. Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol. Cell. Biol. 15:540-551.
17. Graham, F.L., and A.J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:456-467.
18. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science (Wash. DC). 244:48-52.
19. Wakita, T., and J.R. Wands. 1994. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J. Biol. Chem. 269:14205-14210.
20. Mizutani, T., N. Kato, M. Hirota, S. K., A. Murakami, and K. Shimotohno. 1995. Inhibition of hepatitis C virus replication by antisense oligonucleotide in cultured cells. Biochem. Biophys. Res. Commun. 212:906-911.
21. Wu, C.H., A. Siddiqui, and G.Y. Wu. 1995. Targeted inhibition of HCV promoter activity using HCV specific antisense DNA. Hepatology. 22:331a. (Abstr.)
22. Feng, M., G. Cabrera, J. Deshane, K.J. Scanlon, and D.T. Curiel. 1995. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res. 55:2024-2028.
23. von Weizsacker, F., H.E. Blum, and J.R. Wands. 1992. Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. Biochem. Biophys. Res. Commun. 189:743-748.
24. Ruiz, J., Y. Ito, C.H. Wu, and G.Y. Wu. 1996. Multimeric tandem ribozymes against hepatitis B. Biotechniques. In press.
25. Wang, C., P. Sarnow, and A. Siddiqui. 1994. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J. Virol. 68:7301-7307.
26. Fukushi, S., K. Katayama, C. Kurihara, N. Ishiyama, F.B. Hoshino, T. Ando, and A. Oya. 1994. Complete 5′ noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA. Biochem. Biophys. Res. Commun. 199:425-432.
27. Rijnbrand, R., P. Bredenbeek, T. van der Straaten, L. Whetter, G. Inchauspe, S. Lemon, and W. Spaan. 1995. Almost the entire 5′ non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett. 365:115-119.
28. Yoo, B.J., M.J. Selby, J. Choe, B.S. Suh, S.H. Choi, J.S. Joh, G.J. Nuovo, H.S. Lee, M. Houghton, and J.H. Han. 1995. Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV. J. Virol. 69:32-38.
29. Enomoto, N., M. Kurosaki, Y. Tanaka, F. Marumo, and C. Sato. 1994. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J. Gen. Virol. 75:1361-1369.
30. Bertolini, L., S. Iacovacci, A. Ponzetto, G. Gorini, M. Battaglia, and G. Carloni. 1993. The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res. Virol. 144:281-285.
31. Carloni, G., S. Iacovacci, M. Sargiacomo, G. Ravagnan, A. Ponzetto, C. Peschle, and M. Battaglia. 1993. Susceptibility of human liver cell cultures to hepatitis C virus infection. Arch. Virol. Suppl. 8:31-39.
32. Lanford, R.E., C. Sureau, J.R. Jacob, R. White, and T.R. Fuerst. 1994. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 202:606-614.
33. Shimizu, Y.K., A. Iwamoto, M. Hijikata, R.H. Purcell, and H. Yoshikura. 1992. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Natl. Acad. Sci. USA. 89:5477-5481.